Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.87ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.47.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DJ.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BW.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.39.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.233ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.320ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.635ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used